News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Celsis In Vitro Technologies (CEL.L) Introduces New Assay-Specific Human Liver Microsomes



2/11/2008 11:03:28 AM

CHICAGO--(BUSINESS WIRE)--Celsis In Vitro Technologies Inc. (Celsis IVT), a division of the global life sciences company Celsis International plc, today announced the availability of Celsis InVitroCYP microsomes for pre-clinical research. As the first microsome product line formulated to deliver different classifications of cytochrome P450 (CYP) enzyme activity—high levels for inhibitions studies (InVitroCYP H-class), moderate levels for metabolic studies (InVitroCYP M-class) and custom activity levels (InVitroCYP C-class)—Celsis InVitroCYPs now enable researchers to choose a microsome product to optimize their specific study outcomes.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES